Imprivata Agrees To Be Acquired By Thoma Bravo For $19.25 Per Share
Imprivata announced that it has entered into a definitive agreement to be acquired by an affiliate of Thoma Bravo, a private equity investment firm. Under the terms of the agreement, shareholders of record will receive $19.25 in cash per share of Imprivata common stock, which represents a 33% premium to Imprivata's last closing stock price of $14.50.
The value of the transaction is approximately $544M. "We're tremendously excited about Thoma Bravo's investment in our company and believe this transaction represents a great outcome for our current shareholders. Given Thoma Bravo's successful track record in both security and healthcare IT, today's partnership is an endorsement of Imprivata's corporate vision and our relentless focus on the customer experience -- a value which has established us as the vendor of choice in healthcare IT security," said Omar Hussain, President and CEO of Imprivata.
Disclosure: None.